STOCK TITAN

[Form 4] Galecto, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Galecto (NASDAQ: GLTO) submitted a routine Form 4 detailing a small insider equity grant.

On 18 June 2025, director Amit Munshi received a stock option for 720 common shares at an exercise price of $3.22 per share. The grant was issued under the company’s Non-Employee Director Compensation Policy in conjunction with the 2025 Annual Meeting. The option vests in equal monthly installments over one year and expires on 18 June 2035. Following the transaction, Munshi beneficially owns 720 derivative securities; no non-derivative share holdings were reported.

The filing is administrative in nature, disclosing routine director compensation with no material impact on Galecto’s financial position or governance profile.

Galecto (NASDAQ: GLTO) ha presentato un modulo Form 4 di routine che dettaglia una piccola concessione di azioni interne.

Il 18 giugno 2025, il direttore Amit Munshi ha ricevuto un opzione su azioni per 720 azioni ordinarie con un prezzo di esercizio di 3,22 $ per azione. La concessione è stata emessa secondo la Politica di Compensazione per Direttori Non Dipendenti dell’azienda in occasione dell’Assemblea Annuale 2025. L’opzione matura in rate mensili uguali nell’arco di un anno e scade il 18 giugno 2035. Dopo questa operazione, Munshi detiene beneficiariamente 720 strumenti derivati; non sono state segnalate partecipazioni in azioni non derivate.

La comunicazione è di natura amministrativa, rivelando una compensazione ordinaria per il direttore senza alcun impatto rilevante sulla posizione finanziaria o sul profilo di governance di Galecto.

Galecto (NASDAQ: GLTO) presentó un Formulario 4 rutinario que detalla una pequeña concesión de acciones internas.

El 18 de junio de 2025, el director Amit Munshi recibió una opción sobre 720 acciones comunes con un precio de ejercicio de $3.22 por acción. La concesión se otorgó bajo la Política de Compensación para Directores No Empleados de la empresa en relación con la Reunión Anual 2025. La opción se consolida en cuotas mensuales iguales durante un año y vence el 18 de junio de 2035. Tras la transacción, Munshi posee beneficiosamente 720 valores derivados; no se reportaron participaciones en acciones no derivadas.

La presentación es de carácter administrativo, revelando una compensación rutinaria para directores sin impacto material en la posición financiera o el perfil de gobernanza de Galecto.

Galecto (NASDAQ: GLTO)는 소규모 내부자 주식 부여를 상세히 설명하는 정기 Form 4를 제출했습니다.

2025년 6월 18일, 이사 Amit Munshi는 주당 3.22달러의 행사 가격으로 720 보통주에 대한 스톡 옵션을 받았습니다. 이 부여는 2025년 연례 회의와 관련하여 회사의 비임원 이사 보상 정책에 따라 발행되었습니다. 옵션은 1년 동안 매월 동일한 비율로 베스팅되며 2035년 6월 18일에 만료됩니다. 거래 후 Munshi는 720개의 파생 증권을 실질적으로 보유하게 되었으며, 비파생 주식 보유는 보고되지 않았습니다.

이 제출은 행정적인 성격으로, Galecto의 재무 상태나 거버넌스 프로필에 중대한 영향 없이 정기적인 이사 보상을 공개하는 것입니다.

Galecto (NASDAQ : GLTO) a soumis un formulaire 4 de routine détaillant une petite attribution d’actions aux initiés.

Le 18 juin 2025, le directeur Amit Munshi a reçu une option d’achat portant sur 720 actions ordinaires au prix d’exercice de 3,22 $ par action. Cette attribution a été émise dans le cadre de la politique de rémunération des administrateurs non salariés de la société, en lien avec l’assemblée générale annuelle de 2025. L’option devient acquise par tranches mensuelles égales sur une année et expire le 18 juin 2035. À la suite de cette opération, Munshi détient effectivement 720 titres dérivés ; aucune détention d’actions non dérivées n’a été déclarée.

Le dépôt est de nature administrative, révélant une rémunération habituelle des administrateurs sans impact significatif sur la situation financière ou le profil de gouvernance de Galecto.

Galecto (NASDAQ: GLTO) hat ein routinemäßiges Formular 4 eingereicht, das eine kleine Insider-Aktienzuteilung beschreibt.

Am 18. Juni 2025 erhielt Direktor Amit Munshi eine Optionszuteilung für 720 Stammaktien zu einem Ausübungspreis von 3,22 $ pro Aktie. Die Zuteilung erfolgte gemäß der Vergütungspolitik für nicht geschäftsführende Direktoren des Unternehmens im Zusammenhang mit der Hauptversammlung 2025. Die Option fällt in gleichen monatlichen Raten über ein Jahr an und läuft am 18. Juni 2035 ab. Nach der Transaktion besitzt Munshi wirtschaftlich 720 derivative Wertpapiere; keine nicht-derivativen Aktienbestände wurden gemeldet.

Die Einreichung ist administrativer Natur und offenbart eine routinemäßige Direktorenvergütung ohne wesentliche Auswirkungen auf die finanzielle Lage oder das Governance-Profil von Galecto.

Positive
  • None.
Negative
  • None.

Galecto (NASDAQ: GLTO) ha presentato un modulo Form 4 di routine che dettaglia una piccola concessione di azioni interne.

Il 18 giugno 2025, il direttore Amit Munshi ha ricevuto un opzione su azioni per 720 azioni ordinarie con un prezzo di esercizio di 3,22 $ per azione. La concessione è stata emessa secondo la Politica di Compensazione per Direttori Non Dipendenti dell’azienda in occasione dell’Assemblea Annuale 2025. L’opzione matura in rate mensili uguali nell’arco di un anno e scade il 18 giugno 2035. Dopo questa operazione, Munshi detiene beneficiariamente 720 strumenti derivati; non sono state segnalate partecipazioni in azioni non derivate.

La comunicazione è di natura amministrativa, rivelando una compensazione ordinaria per il direttore senza alcun impatto rilevante sulla posizione finanziaria o sul profilo di governance di Galecto.

Galecto (NASDAQ: GLTO) presentó un Formulario 4 rutinario que detalla una pequeña concesión de acciones internas.

El 18 de junio de 2025, el director Amit Munshi recibió una opción sobre 720 acciones comunes con un precio de ejercicio de $3.22 por acción. La concesión se otorgó bajo la Política de Compensación para Directores No Empleados de la empresa en relación con la Reunión Anual 2025. La opción se consolida en cuotas mensuales iguales durante un año y vence el 18 de junio de 2035. Tras la transacción, Munshi posee beneficiosamente 720 valores derivados; no se reportaron participaciones en acciones no derivadas.

La presentación es de carácter administrativo, revelando una compensación rutinaria para directores sin impacto material en la posición financiera o el perfil de gobernanza de Galecto.

Galecto (NASDAQ: GLTO)는 소규모 내부자 주식 부여를 상세히 설명하는 정기 Form 4를 제출했습니다.

2025년 6월 18일, 이사 Amit Munshi는 주당 3.22달러의 행사 가격으로 720 보통주에 대한 스톡 옵션을 받았습니다. 이 부여는 2025년 연례 회의와 관련하여 회사의 비임원 이사 보상 정책에 따라 발행되었습니다. 옵션은 1년 동안 매월 동일한 비율로 베스팅되며 2035년 6월 18일에 만료됩니다. 거래 후 Munshi는 720개의 파생 증권을 실질적으로 보유하게 되었으며, 비파생 주식 보유는 보고되지 않았습니다.

이 제출은 행정적인 성격으로, Galecto의 재무 상태나 거버넌스 프로필에 중대한 영향 없이 정기적인 이사 보상을 공개하는 것입니다.

Galecto (NASDAQ : GLTO) a soumis un formulaire 4 de routine détaillant une petite attribution d’actions aux initiés.

Le 18 juin 2025, le directeur Amit Munshi a reçu une option d’achat portant sur 720 actions ordinaires au prix d’exercice de 3,22 $ par action. Cette attribution a été émise dans le cadre de la politique de rémunération des administrateurs non salariés de la société, en lien avec l’assemblée générale annuelle de 2025. L’option devient acquise par tranches mensuelles égales sur une année et expire le 18 juin 2035. À la suite de cette opération, Munshi détient effectivement 720 titres dérivés ; aucune détention d’actions non dérivées n’a été déclarée.

Le dépôt est de nature administrative, révélant une rémunération habituelle des administrateurs sans impact significatif sur la situation financière ou le profil de gouvernance de Galecto.

Galecto (NASDAQ: GLTO) hat ein routinemäßiges Formular 4 eingereicht, das eine kleine Insider-Aktienzuteilung beschreibt.

Am 18. Juni 2025 erhielt Direktor Amit Munshi eine Optionszuteilung für 720 Stammaktien zu einem Ausübungspreis von 3,22 $ pro Aktie. Die Zuteilung erfolgte gemäß der Vergütungspolitik für nicht geschäftsführende Direktoren des Unternehmens im Zusammenhang mit der Hauptversammlung 2025. Die Option fällt in gleichen monatlichen Raten über ein Jahr an und läuft am 18. Juni 2035 ab. Nach der Transaktion besitzt Munshi wirtschaftlich 720 derivative Wertpapiere; keine nicht-derivativen Aktienbestände wurden gemeldet.

Die Einreichung ist administrativer Natur und offenbart eine routinemäßige Direktorenvergütung ohne wesentliche Auswirkungen auf die finanzielle Lage oder das Governance-Profil von Galecto.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Munshi Amit

(Last) (First) (Middle)
OLE MAALOES VEJ 3
C/O GALECTO, INC.

(Street)
COPENHAGEN N G7 G7 DK-2200

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Galecto, Inc. [ GLTO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $3.22 06/18/2025 A 720 (1) 06/18/2035 Common Stock 720 $0 720 D
Explanation of Responses:
1. Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
/s/ Hans T. Schambye, attorney-in-fact 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Galecto Inc.

NASDAQ:GLTO

GLTO Rankings

GLTO Latest News

GLTO Latest SEC Filings

GLTO Stock Data

4.68M
1.27M
3.46%
13.05%
1.39%
Biotechnology
Pharmaceutical Preparations
Link
Denmark
BOSTON